» Articles » PMID: 33023738

COVID-19-related Intracranial Imaging Findings: a Large Single-centre Experience

Overview
Journal Clin Radiol
Specialty Radiology
Date 2020 Oct 7
PMID 33023738
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To describe the neuroradiological changes in patients with coronavirus disease 2019 (COVID-19).

Materials And Methods: A retrospective review was undertaken of 3,403 patients who were confirmed positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and admitted to Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK between 1 March 2020 and 31 May 2020, and who underwent neuroimaging. Abnormal brain imaging was evaluated in detail and various imaging patterns on magnetic resonance imaging MRI were identified.

Results: Of the 3,403 patients with COVID-19, 167 (4.9%) had neurological signs or symptoms warranting neuroimaging. The most common indications were delirium (44/167, 26%), focal neurology (37/167, 22%), and altered consciousness (34/167, 20%). Neuroimaging showed abnormalities in 23% of patients, with MRI being abnormal in 20 patients and computed tomography (CT) in 18 patients. The most consistent neuroradiological finding was microhaemorrhage with a predilection for the splenium of the corpus callosum (12/20, 60%) followed by acute or subacute infarct (5/20, 25%), watershed white matter hyperintensities (4/20, 20%), and susceptibility changes on susceptibility-weighted imaging (SWI) in the superficial veins (3/20, 15%), acute haemorrhagic necrotising encephalopathy (2/20, 10%), large parenchymal haemorrhage (2/20, 10%), subarachnoid haemorrhage (1/20, 5%), hypoxic-ischaemic changes (1/20, 5%), and acute disseminated encephalomyelitis (ADEM)-like changes (1/20, 5%).

Conclusion: Various imaging patterns on MRI were observed including acute haemorrhagic necrotising encephalopathy, white matter hyperintensities, hypoxic-ischaemic changes, ADEM-like changes, and stroke. Microhaemorrhages were the most common findings. Prolonged hypoxaemia, consumption coagulopathy, and endothelial disruption are the likely pathological drivers and reflect disease severity in this patient cohort.

Citing Articles

Structural brain changes in post-COVID condition and its relationship with cognitive impairment.

Pacheco-Jaime L, Garcia-Vicente C, Ariza M, Cano N, Garolera M, Carreras-Vidal L Brain Commun. 2025; 7(1):fcaf070.

PMID: 40008326 PMC: 11851114. DOI: 10.1093/braincomms/fcaf070.


Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health.

Fekete M, Lehoczki A, Szappanos A, Toth A, Mahdi M, Sotonyi P Geroscience. 2025; 47(1):745-779.

PMID: 39777702 PMC: 11872997. DOI: 10.1007/s11357-024-01487-4.


Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations.

Rua C, Raman B, Rodgers C, Newcombe V, Manktelow A, Chatfield D Brain. 2024; 147(12):4121-4130.

PMID: 39375207 PMC: 7616766. DOI: 10.1093/brain/awae215.


Metabolic changes assessed by 1H MR spectroscopy in the corpus callosum of post-COVID patients.

Pajuelo D, Dezortova M, Hajek M, Ibrahimova M, Ibrahim I MAGMA. 2024; 37(5):937-946.

PMID: 38865058 PMC: 11452436. DOI: 10.1007/s10334-024-01171-w.


Neurological and neuropsychiatric manifestations in hospitalised patients with COVID-19.

Lekpeh G, Salie M, van den Heuvel L, Seedat S S Afr J Psychiatr. 2023; 29:2112.

PMID: 38059198 PMC: 10696520. DOI: 10.4102/sajpsychiatry.v29i0.2112.


References
1.
Ross Reichard R, Kashani K, Boire N, Constantopoulos E, Guo Y, Lucchinetti C . Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020; 140(1):1-6. PMC: 7245994. DOI: 10.1007/s00401-020-02166-2. View

2.
Jain R . Evolving Neuroimaging Findings during COVID-19. AJNR Am J Neuroradiol. 2020; 41(8):1355-1356. PMC: 7658897. DOI: 10.3174/ajnr.A6658. View

3.
Franceschi A, Ahmed O, Giliberto L, Castillo M . Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection. AJNR Am J Neuroradiol. 2020; 41(7):1173-1176. PMC: 7357664. DOI: 10.3174/ajnr.A6595. View

4.
Varatharaj A, Thomas N, Ellul M, Davies N, Pollak T, Tenorio E . Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020; 7(10):875-882. PMC: 7316461. DOI: 10.1016/S2215-0366(20)30287-X. View

5.
Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View